Interaction between mitochondria and microbiota modulating cellular metabolism in inflammatory bowel disease.

Bacterial metabolites Cellular metabolism Inflammatory bowel disease (IBD) Mitochondria-microbiota interaction Mitochondrial DNA (mtDNA) polymorphisms Mitochondrial reactive oxygen species (ROS)

Journal

Journal of molecular medicine (Berlin, Germany)
ISSN: 1432-1440
Titre abrégé: J Mol Med (Berl)
Pays: Germany
ID NLM: 9504370

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 24 07 2023
accepted: 25 09 2023
revised: 06 09 2023
medline: 6 12 2023
pubmed: 11 10 2023
entrez: 11 10 2023
Statut: ppublish

Résumé

Inflammatory bowel disease (IBD) is a prototypic complex disease in the gastrointestinal tract that has been increasing in incidence and prevalence in recent decades. Although the precise pathophysiology of IBD remains to be elucidated, a large body of evidence suggests the critical roles of mitochondria and intestinal microbiota in the pathogenesis of IBD. In addition to their contributions to the disease, both mitochondria and gut microbes may interact with each other and modulate disease-causing cell activities. Therefore, we hypothesize that dissecting this unique interaction may help to identify novel pathways involved in IBD, which will further contribute to discovering new therapeutic approaches to the disease. As poorly treated IBD significantly affects the quality of life of patients and is associated with risks and complications, successful treatment is crucial. In this review, we stratify previously reported experimental and clinical observations of the role of mitochondria and intestinal microbiota in IBD. Additionally, we review the intercommunication between mitochondria, and the intestinal microbiome in patients with IBD is reviewed along with the potential mediators for these interactions. We specifically focus on their roles in cellular metabolism in intestinal epithelial cells and immune cells. To this end, we propose a potential therapeutic intervention strategy for IBD.

Identifiants

pubmed: 37819377
doi: 10.1007/s00109-023-02381-w
pii: 10.1007/s00109-023-02381-w
pmc: PMC10698103
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1513-1526

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : 454193335

Informations de copyright

© 2023. The Author(s).

Références

Lancet Gastroenterol Hepatol. 2022 Feb;7(2):141-151
pubmed: 34863330
Cell Metab. 2017 Jun 6;25(6):1254-1268.e7
pubmed: 28591633
Nature. 2017 Jul 13;547(7662):173-178
pubmed: 28658209
Gut. 2013 Apr;62(4):531-9
pubmed: 22993202
Microbiol Spectr. 2022 Aug 31;10(4):e0065722
pubmed: 35730951
J Appl Microbiol. 2021 Jun;130(6):1823-1838
pubmed: 33098703
Nat Genet. 2017 Feb;49(2):186-192
pubmed: 28067910
Cell Host Microbe. 2015 May 13;17(5):662-71
pubmed: 25865369
J Crohns Colitis. 2019 Jan 01;13(1):27-38
pubmed: 30247650
FASEB J. 2021 Nov;35(11):e21854
pubmed: 34597422
J Lipid Res. 2016 Jun;57(6):943-54
pubmed: 27080715
Aliment Pharmacol Ther. 1996 Oct;10(5):729-36
pubmed: 8899080
Gene Ther. 2007 Sep;14(18):1309-18
pubmed: 17597792
Nature. 2020 Jul;583(7817):631-637
pubmed: 32641830
PLoS One. 2020 Sep 18;15(9):e0238910
pubmed: 32946509
Front Physiol. 2017 May 19;8:319
pubmed: 28579962
Trends Biochem Sci. 2022 Aug;47(8):645-659
pubmed: 35397926
Inflamm Bowel Dis. 2019 Aug 20;25(9):1450-1461
pubmed: 30918945
Nat Genet. 2015 Sep;47(9):979-986
pubmed: 26192919
Mucosal Immunol. 2022 Apr;15(4):595-604
pubmed: 35534699
Inflamm Bowel Dis. 2019 Oct 18;25(11):1751-1763
pubmed: 31498864
Microbiome. 2020 Feb 3;8(1):12
pubmed: 32014035
Nat Genet. 2011 Mar;43(3):246-52
pubmed: 21297633
Gastroenterology. 1993 Mar;104(3):802-9
pubmed: 8440437
Nat Commun. 2020 Jan 3;11(1):102
pubmed: 31900386
Infect Immun. 2018 Dec 19;87(1):
pubmed: 30323021
Nat Rev Gastroenterol Hepatol. 2012 Oct;9(10):599-608
pubmed: 22907164
Science. 2013 Aug 2;341(6145):569-73
pubmed: 23828891
Annu Rev Physiol. 2022 Feb 10;84:435-459
pubmed: 34614372
Front Immunol. 2022 Feb 14;13:822867
pubmed: 35237268
Gastroenterology. 2007 Jun;132(7):2313-9
pubmed: 17570206
J Biomed Sci. 2002;9(6 Pt 1):534-41
pubmed: 12372991
Inflamm Bowel Dis. 2009 Jan;15(1):17-24
pubmed: 18668682
Immunity. 2013 Apr 18;38(4):633-43
pubmed: 23601682
Gut. 2004 Nov;53(11):1632-8
pubmed: 15479684
Front Immunol. 2019 Jul 03;10:1462
pubmed: 31333642
Nat Commun. 2018 Mar 6;9(1):827
pubmed: 29511166
J Immunol. 1999 Jul 15;163(2):1081-90
pubmed: 10395708
Gut. 2022 Dec;71(12):2574-2586
pubmed: 36113981
Mucosal Immunol. 2018 Jan;11(1):120-130
pubmed: 28401939
Annu Rev Genet. 2005;39:359-407
pubmed: 16285865
World J Gastroenterol. 2014 Nov 7;20(41):15216-32
pubmed: 25386070
Gut. 2001 Jul;49(1):35-41
pubmed: 11413108
Immunity. 2013 Feb 21;38(2):225-36
pubmed: 23415911
Gastroenterology. 2012 Mar;142(3):473-481.e4
pubmed: 22155172
Nat Immunol. 2017 Apr 18;18(5):488-498
pubmed: 28418387
Cell Metab. 2020 Oct 6;32(4):514-523
pubmed: 32946809
Nat Commun. 2022 Jun 14;13(1):3432
pubmed: 35701435
Mol Ther. 2022 Feb 2;30(2):726-744
pubmed: 34217890
Nat Rev Mol Cell Biol. 2018 Nov;19(11):713-730
pubmed: 30143745
Gastroenterology. 2016 Oct;151(4):616-32
pubmed: 27436072
Clin Nutr. 2010 Dec;29(6):738-44
pubmed: 20471725
Nat Microbiol. 2019 Feb;4(2):293-305
pubmed: 30531976
Eur J Gastroenterol Hepatol. 1997 Feb;9(2):163-8
pubmed: 9058627
Annu Rev Pharmacol Toxicol. 2018 Jan 6;58:353-389
pubmed: 28961065
World J Gastroenterol. 2009 Jan 14;15(2):169-76
pubmed: 19132766
Gut. 2020 Nov;69(11):1928-1938
pubmed: 32111635
Gastroenterology. 2013 Nov;145(5):1055-1063.e3
pubmed: 23872498
Microbiome. 2019 May 15;7(1):75
pubmed: 31092280
Cell. 2022 May 12;185(10):1764-1776.e12
pubmed: 35472302
Inflamm Bowel Dis. 2022 Mar 30;28(4):639-648
pubmed: 34871402
Nat Commun. 2019 Jan 3;10(1):38
pubmed: 30604764
Mucosal Immunol. 2015 Jan;8(1):80-93
pubmed: 24917457
Free Radic Biol Med. 2015 Aug;85:219-27
pubmed: 25881551
Nat Med. 2013 Sep;19(9):1111-3
pubmed: 23913125
Arch Biochem Biophys. 1994 Mar;309(2):254-60
pubmed: 8135535
Am J Physiol Gastrointest Liver Physiol. 2021 Jan 1;320(2):G125-G135
pubmed: 33084401
Mucosal Immunol. 2018 May;11(3):752-762
pubmed: 29411774
Mol Cell Biochem. 2010 Sep;342(1-2):111-5
pubmed: 20440543
Biomaterials. 2023 Jan;292:121937
pubmed: 36495803
Gastroenterology. 2017 Feb;152(2):313-321.e2
pubmed: 27793607
Blood Purif. 2015;40(4):306-11
pubmed: 26656941
Gut. 2011 Dec;60(12):1739-53
pubmed: 21300624
Inflamm Bowel Dis. 2020 Jan 1;26(1):11-20
pubmed: 31560044
Front Immunol. 2022 Feb 03;13:829525
pubmed: 35185922
Nat Commun. 2022 Feb 8;13(1):750
pubmed: 35136065
Sci Rep. 2017 Nov 10;7(1):15293
pubmed: 29127319
Exp Mol Med. 2017 May 26;49(5):e338
pubmed: 28546564
Front Immunol. 2019 Jul 02;10:1499
pubmed: 31312204
J Mol Med (Berl). 2018 Apr;96(3-4):281-299
pubmed: 29349500
Eur J Clin Microbiol Infect Dis. 2019 Jul;38(7):1211-1221
pubmed: 30945014
Proteomics. 2006 Oct;6(19):5322-31
pubmed: 16947118
Front Physiol. 2017 Jun 30;8:460
pubmed: 28713289
Gut. 1991 Sep;32(9):1071-5
pubmed: 1916494
PLoS One. 2022 Dec 20;17(12):e0279277
pubmed: 36538512
Nat Rev Dis Primers. 2020 Sep 10;6(1):74
pubmed: 32913180
Cell. 2013 Jun 6;153(6):1239-51
pubmed: 23746840
Gut. 2020 Nov;69(11):1939-1951
pubmed: 32111634
Nature. 2011 Jan 20;469(7330):415-8
pubmed: 21113151
Annu Rev Immunol. 2018 Apr 26;36:461-488
pubmed: 29677474
Nat Rev Dis Primers. 2020 Apr 2;6(1):22
pubmed: 32242028
Inflamm Bowel Dis. 2008 Oct;14(10):1432-42
pubmed: 18484669
EMBO Mol Med. 2014 Apr;6(4):458-66
pubmed: 24567072
FASEB J. 2007 Jan;21(1):197-206
pubmed: 17135366
Nat Rev Gastroenterol Hepatol. 2017 Oct;14(10):573-584
pubmed: 28743984
Cell. 2012 Mar 16;148(6):1145-59
pubmed: 22424226
Nat Rev Mol Cell Biol. 2020 Feb;21(2):85-100
pubmed: 31636403
Life Sci. 2017 Nov 15;189:29-38
pubmed: 28912045
Inflamm Bowel Dis. 2011 Sep;17(9):1971-8
pubmed: 21830275
Annu Rev Public Health. 2019 Apr 1;40:261-282
pubmed: 30633714
PLoS Genet. 2014 May 22;10(5):e1004369
pubmed: 24852434
PLoS One. 2016 May 27;11(5):e0156334
pubmed: 27232601
Gut. 2018 Mar;67(3):574-587
pubmed: 29141957
Nat Commun. 2021 Feb 19;12(1):1190
pubmed: 33608520
Immunity. 2017 Mar 21;46(3):488-503
pubmed: 28285833
Annu Rev Pharmacol Toxicol. 2007;47:143-83
pubmed: 17029566
Nat Med. 2018 Nov;24(11):1691-1695
pubmed: 30250142
Gut. 2004 Nov;53(11):1624-31
pubmed: 15479683
Int J Mol Sci. 2021 Jan 20;22(3):
pubmed: 33498298
BMC Gastroenterol. 2016 Oct 3;16(1):118
pubmed: 27716073
Redox Biol. 2021 Jan;38:101772
pubmed: 33137711
Front Immunol. 2019 Mar 11;10:277
pubmed: 30915065
Nat Genet. 2010 Dec;42(12):1118-25
pubmed: 21102463
NPJ Syst Biol Appl. 2021 May 6;7(1):19
pubmed: 33958598
Scand J Gastroenterol. 2002 Apr;37(4):458-66
pubmed: 11989838
Inflamm Bowel Dis. 2015 Jun;21(6):1297-305
pubmed: 25901973
Nat Genet. 2017 Feb;49(2):256-261
pubmed: 28067908
Annu Rev Pathol. 2010;5:297-348
pubmed: 20078222
Cell Metab. 2021 Dec 7;33(12):2355-2366.e8
pubmed: 34847376
Gut. 2020 Dec;69(12):2232-2243
pubmed: 32917747
Inflamm Bowel Dis. 2012 Nov;18(11):2158-68
pubmed: 22374887
Scand J Gastroenterol. 2017 Nov;52(11):1185-1193
pubmed: 28697651
N Engl J Med. 2020 Dec 31;383(27):2652-2664
pubmed: 33382932
Int J Mol Sci. 2019 May 13;20(9):
pubmed: 31085998
Lancet Gastroenterol Hepatol. 2020 Jan;5(1):17-30
pubmed: 31648971
J Pediatr Gastroenterol Nutr. 2004 May;38(5):534-8
pubmed: 15097444
United European Gastroenterol J. 2022 Dec;10(10):1113-1120
pubmed: 36251359
Microb Ecol Health Dis. 2015 Feb 02;26:26191
pubmed: 25651997
Cell Signal. 2020 Nov;75:109737
pubmed: 32810578
Gastroenterology. 2020 Sep;159(3):956-968.e8
pubmed: 32485177
JAMA. 2019 Jan 15;321(2):156-164
pubmed: 30644982
Nat Rev Genet. 2021 Feb;22(2):106-118
pubmed: 32989265
Nat Commun. 2016 Nov 23;7:13419
pubmed: 27876802
Immunity. 2014 Jan 16;40(1):128-39
pubmed: 24412617
Nature. 2011 Jan 13;469(7329):221-5
pubmed: 21124315
Cell Mol Gastroenterol Hepatol. 2021;12(1):229-250
pubmed: 33515804
Immunother Adv. 2020 Nov 12;1(1):ltaa002
pubmed: 36284899
Mol Metab. 2022 Sep;63:101546
pubmed: 35817394
Cells. 2022 Jan 19;11(3):
pubmed: 35159135
Sci Signal. 2019 Jul 02;12(588):
pubmed: 31266851
Nat Rev Endocrinol. 2022 Apr;18(4):243-258
pubmed: 35145250
Nat Commun. 2019 Feb 15;10(1):760
pubmed: 30770822
Inflamm Bowel Dis. 2021 Oct 18;27(10):1684-1693
pubmed: 33693743
Nature. 2019 Jan;565(7740):495-499
pubmed: 30626970

Auteurs

Misa Hirose (M)

Lübeck Institute of Experimental Dermatology, University of Lübeck, Ratzeburger Allee 160, 23562, Lübeck, Germany.

Priyadharshini Sekar (P)

Sharjah Institute of Medical Research, RIMHS, University of Sharjah, Sharjah, United Arab Emirates.

Mariam Wed Abdelaziz Eladham (MWA)

Sharjah Institute of Medical Research, RIMHS, University of Sharjah, Sharjah, United Arab Emirates.

Mohammad T Albataineh (MT)

College of Medicine and Health Sciences, Khalifa University, Abu Dhabi, United Arab Emirates.

Mohamed Rahmani (M)

College of Medicine and Health Sciences, Khalifa University, Abu Dhabi, United Arab Emirates.

Saleh Mohamed Ibrahim (SM)

Lübeck Institute of Experimental Dermatology, University of Lübeck, Ratzeburger Allee 160, 23562, Lübeck, Germany. saleh.ibrahim@ku.ac.ae.
College of Medicine and Health Sciences, Khalifa University, Abu Dhabi, United Arab Emirates. saleh.ibrahim@ku.ac.ae.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH